Carolyn Tallon

Carolyn Tallon

Johns Hopkins University

H-index: 10

North America-United States

About Carolyn Tallon

Carolyn Tallon, With an exceptional h-index of 10 and a recent h-index of 10 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Neurodegenerative disease, drug development, in vivo pharmacology, microscopy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

Inhibition of EV biogenesis reduces tau propagation in Alzheimer’s Disease mouse models

Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice

Compositions and methods comprising dendrimers and therapeutic agents

ASENT 2023 Annual Meeting Abstracts

nSMase2 inhibition reduces tau propagation in Alzheimer’s Disease mouse models

Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug

Effects of 6-Aminonicotinic Acid Esters on the Reprogrammed Epigenetic State of Distant Metastatic Pancreatic Carcinoma

Carolyn Tallon Information

University

Position

Postdoctoral Fellow

Citations(all)

266

Citations(since 2020)

244

Cited By

70

hIndex(all)

10

hIndex(since 2020)

10

i10Index(all)

10

i10Index(since 2020)

10

Email

University Profile Page

Google Scholar

Carolyn Tallon Skills & Research Interests

Neurodegenerative disease

drug development

in vivo pharmacology

microscopy

Top articles of Carolyn Tallon

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

Translational Neurodegeneration

2023/12/4

Inhibition of EV biogenesis reduces tau propagation in Alzheimer’s Disease mouse models

Alzheimer's & Dementia

2023/12

Carolyn Tallon
Carolyn Tallon

H-Index: 4

Rana Rais
Rana Rais

H-Index: 20

Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice

Pharmaceutics

2023/9/21

Compositions and methods comprising dendrimers and therapeutic agents

2023/7/13

ASENT 2023 Annual Meeting Abstracts

2023

nSMase2 inhibition reduces tau propagation in Alzheimer’s Disease mouse models

Alzheimer's & Dementia

2022/12

Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug

Science Advances

2022/11/16

Effects of 6-Aminonicotinic Acid Esters on the Reprogrammed Epigenetic State of Distant Metastatic Pancreatic Carcinoma

ACS Medicinal Chemistry Letters

2022/11/7

Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice

Pharmaceutics

2022/9/28

Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis

Neurotherapeutics

2022/1

Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis

Nanotheranostics

2022

Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury

Biochemical pharmacology

2021/12/1

The neutral sphingomyelinase 2 inhibitor PDDC reduces tau burden in Alzheimer’s disease mice

Alzheimer's & Dementia

2021/12

Regulatory T cells reduce endothelial neutral sphingomyelinase 2 to prevent T‐cell migration into tumors

European Journal of Immunology

2021/9

Carolyn Tallon
Carolyn Tallon

H-Index: 4

Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases

2021/7/1

Sowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer’s Disease

2020/10/14

Carolyn Tallon
Carolyn Tallon

H-Index: 4

Pharmacological BACE inhibition improves axonal regeneration in nerve injury and disease models

Neurotherapeutics

2020/7/1

Carolyn Tallon
Carolyn Tallon

H-Index: 4

Novel human neutral sphingomyelinase 2 inhibitors as potential therapeutics for Alzheimer’s disease

Journal of medicinal chemistry

2020/4/16

Glutamine antagonist JHU-083 normalizes aberrant hippocampal glutaminase activity and improves cognition in APOE4 mice

Journal of Alzheimer's Disease

2020/1/1

See List of Professors in Carolyn Tallon University(Johns Hopkins University)